My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 153

    1.

    Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study.

    Johnson SL, Tierney EF, Onyemere KU, Tseng CW, Safford MM, Karter AJ, Ferrara A, Duru OK, Brown AF, Narayan KM, Thompson TJ, Herman WH.

    Diabetes Care. 2006 Aug;29(8):1733-8. Erratum in: Diabetes Care. 2006 Nov;29(11):2571. PMID: 16873772 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.

    Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC.

    J Gen Intern Med. 2004 Jun;19(6):669-75.PMID: 15209606 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.

    Maahs DM, Snell-Bergeon JK, Kinney GL, Wadwa RP, Garg S, Ogden LG, Rewers M.

    J Diabetes Complications. 2007 Sep-Oct;21(5):273-9.PMID: 17825750 [PubMed - indexed for MEDLINE]Related articles

    4.

    Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization.

    Cooke CE, Fatodu H.

    J Manag Care Pharm. 2006 Oct;12(8):649-55.PMID: 17269843 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002.

    Rosen AB.

    J Gen Intern Med. 2006 Apr;21(4):315-9.PMID: 16686805 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Angiotensin receptor antagonist vs. angiotensin-converting enzyme inhibitor in Asian subjects with type 2 diabetes and albuminuria - a randomized crossover study.

    Lim SC, Koh AF, Goh SK, Chua CL, Heng BL, Subramaniam T, Sum CF.

    Diabetes Obes Metab. 2007 Jul;9(4):477-82.PMID: 17587389 [PubMed - indexed for MEDLINE]Related articles

    7.

    Use of microalbuminuria testing in persons with type 2 diabetes: are the right patients being tested?

    Hueston WJ, Scibelli S, Mainous III AG.

    J Fam Pract. 2001 Aug;50(8):669-73.PMID: 11509159 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy]

    Kuriyama S, Tomonari H, Ohtsuka Y, Ohkido I, Hosoya T.

    Nippon Jinzo Gakkai Shi. 2003;45(4):367-71. Japanese. PMID: 12806973 [PubMed - indexed for MEDLINE]Related articles

    9.

    Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

    MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

    Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.PMID: 16797382 [PubMed - indexed for MEDLINE]Related articles

    10.

    Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.

    Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, Schelling JR.

    Am J Kidney Dis. 2008 Jan;51(1):29-37.PMID: 18155530 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.

    Jennings DL, Kalus JS, Coleman CI, Manierski C, Yee J.

    Diabet Med. 2007 May;24(5):486-93. Epub 2007 Mar 15.PMID: 17367311 [PubMed - indexed for MEDLINE]Related articles

    12.

    Characteristics of patients prescribed angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or the combination at an urban medical center.

    Masri G, Bledsoe K, Palacio C.

    MedGenMed. 2007 Nov 20;9(4):40.PMID: 18311390 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.

    Böger CA, Haak T, Götz AK, Christ J, Ruff E, Hoffmann U, Riegger GA, Krämer BK.

    Int J Clin Pharmacol Ther. 2006 Aug;44(8):364-74.PMID: 16961167 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

    Weir MR.

    Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

    15.

    Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study.

    Rossing K, Schjoedt KJ, Smidt UM, Boomsma F, Parving HH.

    Diabetes Care. 2005 Sep;28(9):2106-12.PMID: 16123474 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.

    Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J.

    Am J Kidney Dis. 2005 Dec;46(6):1080-7.PMID: 16310574 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.

    Coleman CI, Makanji S, Kluger J, White CM.

    Ann Pharmacother. 2007 Mar;41(3):433-7. Epub 2007 Mar 6.PMID: 17341525 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dual blockade of the renin-angiotensin system in diabetic nephropathy.

    Wade VL, Gleason BL.

    Ann Pharmacother. 2004 Jul-Aug;38(7-8):1278-82. Epub 2004 Jun 8. Review.PMID: 15187210 [PubMed - indexed for MEDLINE]Related articles

    19.

    Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.

    Lee HY, Cooke CE, Robertson TA.

    J Manag Care Pharm. 2008 Apr;14(3):271-80.PMID: 18439049 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center.

    Frazee LA, Samandari S, Tanphaichitr N, Bourguet CC, Pfister EW.

    Am J Ther. 2006 Jan-Feb;13(1):18-23.PMID: 16428918 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity